Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$363M |
| 2 |
Nike
NKE
|
+$289M |
| 3 |
Home Depot
HD
|
+$271M |
| 4 |
Mastercard
MA
|
+$180M |
| 5 |
Amazon
AMZN
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$226M |
| 2 |
Coca-Cola
KO
|
+$225M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Johnson & Johnson
JNJ
|
+$199M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.84% |
| 2 | Healthcare | 12.18% |
| 3 | Financials | 11.43% |
| 4 | Industrials | 9.05% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGNT
2926
DELISTED
Cogentix Medical, Inc.
CGNT
| $324K | ﹤0.01% |
336,663
+17,500
| +5% | +$17.3K |
|
|
LUNA
2927
DELISTED
Luna Innovations Incorporated
LUNA
| $324K | ﹤0.01% |
261,005
+70,500
| +37% | +$77.4K |
|
|
OCRX
2928
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $321K | ﹤0.01% |
169,100
+22,700
| +16% | +$59.7K |
|
2929
Colony Bankcorp
CBAN
$471M
| $318K | ﹤0.01% |
33,400
+1,600
| +5% | +$15.2K |
|
2930
Gorman-Rupp
GRC
$2.11B
| $318K | ﹤0.01% |
11,600
+1,900
| +20% | +$52.9K |
|
|
JAX
2931
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $318K | ﹤0.01% |
+32,000
| New | +$326K |
|
|
SYUT
2932
DELISTED
Synutra International, Inc.
SYUT
| $317K | ﹤0.01% |
83,100
+4,100
| +5% | +$18.4K |
|
|
TISA
2933
DELISTED
TOP Image Systems Ltd
TISA
| $316K | ﹤0.01% |
164,648
-7,652
| -4% | -$12.8K |
|
|
UFS
2934
DELISTED
DOMTAR CORPORATION (New)
UFS
| $314K | ﹤0.01% |
9,000
-33,200
| -79% | -$1.28M |
|
|
CCXI
2935
DELISTED
ChemoCentryx, Inc.
CCXI
| $313K | ﹤0.01% |
69,681
-99,373
| -59% | -$373K |
|
2936
Clearway Energy Class C
CWEN
$7.02B
| $312K | ﹤0.01% |
+20,000
| New | +$305K |
|
2937
Urban One Class A
UONE
$23.5M
| $312K | ﹤0.01% |
9,960
+20
| +0.2% | +$455 |
|
2938
Fate Therapeutics
FATE
$294M
| $307K | ﹤0.01% |
180,700
-42,000
| -19% | -$76.1K |
|
2939
Home BancShares
HOMB
$6.27B
| $307K | ﹤0.01% |
15,500
-180,300
| -92% | -$3.78M |
|
|
ENFC
2940
DELISTED
Entegra Financial Corp.
ENFC
| $306K | ﹤0.01% |
17,500
+3,200
| +22% | +$56.1K |
|
|
ADYX
2941
DELISTED
Adynxx Inc
ADYX
| $304K | ﹤0.01% |
4,525
+2,228
| +97% | +$133K |
|
2942
AMREP Corp
AXR
$118M
| $303K | ﹤0.01% |
61,680
+1,400
| +2% | +$6.24K |
|
|
KAMN
2943
DELISTED
Kaman Corp
KAMN
| $303K | ﹤0.01% |
7,122
-77,278
| -92% | -$3.25M |
|
|
AEY
2944
DELISTED
ADDvantage Technologies Group
AEY
| $300K | ﹤0.01% |
16,970
+640
| +4% | +$11.5K |
|
|
ZGNX
2945
DELISTED
Zogenix, Inc.
ZGNX
| $299K | ﹤0.01% |
37,187
-36,900
| -50% | -$360K |
|
2946
ACNB Corp
ACNB
$660M
| $296K | ﹤0.01% |
+11,800
| New | +$274K |
|
2947
Matrix Service
MTRX
$328M
| $294K | ﹤0.01% |
17,800
-49,559
| -74% | -$836K |
|
|
SUMR
2948
DELISTED
Summer Infant, Inc.
SUMR
| $291K | ﹤0.01% |
19,500
+956
| +5% | +$13.4K |
|
|
SNMP
2949
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $289K | ﹤0.01% |
+880
| New | +$278K |
|
2950
Xenon Pharmaceuticals
XENE
$6.21B
| $286K | ﹤0.01% |
48,500
+14,700
| +43% | +$101K |
|
Similar funds
Jim Simons's Q2 2016 Portfolio in Review
As of Q2 2016, Jim Simons held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Jim Simons withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Jim Simons opened a new position in Nike worth $280M.
- Jim Simons's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
- Jim Simons added most to CVS Health in Q2 2016, an estimated $363M increase.
- Jim Simons's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
- Jim Simons fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
- Jim Simons opened 423 new positions and closed 474 in Q2 2016.
- Jim Simons's portfolio value fell 0.13% quarter-over-quarter to $52.5B.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.